MicroRNA profiling of human gastric cancer.

MicroRNAs are a group of small non-coding RNAs that modulate gene expression. The de-regulation of microRNA expression has been found in several types of cancer. To study the role of microRNAs in gastric cancer (GC), we analyzed the expression profile of 847 microRNAs in GC from Chinese patients. Total RNA was used for hybridization on the miRCURY LNA Array (v. 11.0), which contains probes specific for 847 human microRNAs. The results from the miRNA microarray analysis were validated by real-time RT-PCR. A total of 24 miRNAs with a more than 2-fold change were differentially expressed between normal gastric tissue and GC. Of these, 22 miRNAs (miR-223, miR-106b, miR-147, miR-34a, miR-130b*, miR-106a, miR-18a, miR-17, miR-98, miR-616*, miR-181a-2*, miR-185, miR-1259, miR-601, miR-196a*, miR-221*, miR-302f, miR-340*, miR-337-3p, miR-520c-3p, miR-575 and miR-138) were significantly up-regulated in GC (P<0.05), whereas only miR-638 and miR-378 were significantly down-regulated in GC (P<0.05) compared to normal gastric tissue. The expression of miR-185 and miR-638, as measured by miRNA microarray analysis, was in agreement with the expression level of these microRNAs found by real-time RT-PCR in the same samples. Our results show that microRNAs are de-regulated in GC, suggesting the involvement of these genes in the development and progression of gastric cancer.

[1]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[2]  Y. Fujii,et al.  microRNA expression profile in undifferentiated gastric cancer. , 2009, International journal of oncology.

[3]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[4]  M. Jovanović,et al.  miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.

[5]  Omid Behnamfar,et al.  Adenoviral gene therapy in gastric cancer: a review. , 2008, World journal of gastroenterology.

[6]  T. Wurdinger,et al.  Molecular therapy in the microRNA era , 2007, The Pharmacogenomics Journal.

[7]  M. Ferracin,et al.  MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. , 2009, Free radical biology & medicine.

[8]  A. E. Erson,et al.  An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. , 2009, Cancer genetics and cytogenetics.

[9]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[10]  C. Croce,et al.  MicroRNAs in the ontogeny of leukemias and lymphomas , 2009, Leukemia & lymphoma.

[11]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[12]  D. Fan,et al.  miR-15 b and miR-16 modulate multidrug resistance by targeting BCL 2 in human gastric cancer cells , 2008 .

[13]  Tyler T. Risom,et al.  MicroRNAs in mammalian development. , 2006, Birth defects research. Part C, Embryo today : reviews.

[14]  Bernat Gel,et al.  Overlapping expression of microRNAs in human embryonic colon and colorectal cancer , 2008, Cell Research.

[15]  Nathalie Wong,et al.  MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. , 2008, Gastroenterology.

[16]  Frank J. Slack,et al.  MicroRNAs and cancer: An overview , 2008, Cell cycle.

[17]  F. Slack,et al.  MicroRNA in cancer prognosis. , 2008, The New England journal of medicine.

[18]  Ding‐Shinn Chen,et al.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. , 2009, Gastroenterology.

[19]  Xiao-fang Yu,et al.  Microarray analysis of microRNA expression in hepatocellular carcinoma and non‐tumorous tissues without viral hepatitis , 2007, Journal of gastroenterology and hepatology.

[20]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[21]  M. Kusano,et al.  Gastric and Intestinal Phenotypic Marker Expression in Early Differentiated-Type Tumors of the Stomach: Clinicopathologic Significance and Genetic Background , 2006, Clinical Cancer Research.

[22]  A. Neugut,et al.  Epidemiology of gastric cancer. , 2006, World journal of gastroenterology.

[23]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[24]  M. Malumbres,et al.  Control of cell proliferation pathways by microRNAs , 2008, Cell cycle.

[25]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[27]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[28]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[29]  George A Calin,et al.  Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.

[30]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[31]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[32]  B. Xiao,et al.  Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.

[33]  O. Kent,et al.  Functional integration of microRNAs into oncogenic and tumor suppressor pathways , 2008, Cell cycle.